CUK Q1 2026 Earnings EPS Meets Estimate Narrowly Stock Lifts 66 QMCO Q1 2026 Earnings EPS Beat Estimates but Stock Declines as Revenue Remains Unreported XP Q1 2026 Earnings EPS Miss and Stock Decline Signal Headwinds AVAV Q1 2026 Earnings EPS Misses Estimates as Revenue Data Remains Undisclosed CEVA Q1 2026 Earnings EPS Surprises by 122 Amid Strong Licensing Momentum Kairos Pharma Ltd KAPA Q1 2026 Earnings Widerthanexpected loss and muted stock response amid preclinical focus